Latest AI and machine learning research in skin cancer for healthcare professionals.
Lower-grade glioma (LGG) is a highly heterogeneous disease, making accurate prognosis prediction and the development of precise, personalized treatment plans for patients challenging. The multi-omics data from patients with LGG were analyzed using 10 clustering algorithms to identify subgroups at very high resolution. Ten machine learning algorithms were subsequently integrated to develop a robust...
OBJECTIVE: To provide a structured narrative review of current evidence and future directions for artificial intelligence (AI) applications in the tertiary prevention of lung cancer, with a focus on radiology-driven recurrence surveillance, treatment response assessment, prognostic stratification, and real-world clinical implementation. METHODS: A narrative review was conducted using PubMed, Embas...
OBJECTIVE: Disulfidptosis is a recently discovered mechanism of cell death caused by disulfide stress. Arachidonic acid metabolism (AAM) is one of the...
The interplay between mitochondria and programmed cell deaths (PCD) is associated with tumor pathogenesis. However, the specific roles of genes relate...
Triaptosis, an emerging form of cell death, remains poorly characterized in terms of its heterogeneity within clear cell renal cell carcinoma (ccRCC)....
INTRODUCTION: Artificial intelligence (AI) is reshaping diagnostic paradigms across oncology. In ophthalmic oncology encompassing conditions like reti...
Uveal melanoma (UVM) is an aggressive intraocular malignancy with a high risk of metastasis but few effective therapies. However, current molecular cl...
Multicellular programs in the tumour microenvironment (TME) drive cancer pathogenesis and response to therapy but remain challenging to identify and p...
BACKGROUND: Tumour infiltrating lymphocytes (TILs) are a key component of the tumour microenvironment. To establish a clinically relevant TILs cut-off...
BACKGROUND: Artificial intelligence has significantly advanced computational pathology by enabling high-resolution, clinical-grade tumor segmentation ...
Immunotherapy has long played a pivotal role in cancer treatment, and antigen-presenting cell (APC)-based immunotherapy represents a promising strateg...
Immunotherapy has transformed cancer treatment but remains ineffective in many solid tumors, largely due to the immunosuppressive tumor microenvironme...
BACKGROUND: Melanoma represents a highly aggressive and metastatic form of malignant skin cancer. that remains challenging to treat clinically. Tumor ...
Small cell lung cancer (SCLC) is an aggressive pulmonary neuroendocrine carcinoma characterized by rapid progression and early metastasis. Despite rec...
OBJECTIVE: Automated literature screening in biomedical research is often hindered by domain shifts and scarcity of labeled data, which limit model ac...
The efficacy of PD-1 inhibitor pucotenlimab (HX008) in solid tumors exhibits heterogeneity. This study integrated data from 6 clinical trials (coverin...
BACKGROUND: Oropharyngeal squamous cell carcinoma (OPSCC) accounts for a substantial proportion of head and neck cancers, with a rising incidence larg...
PURPOSE: Circulating tumor fraction estimate (ctFE) is a machine learning-derived composite metric of circulating tumor DNA (ctDNA) burden. We hypothe...
The poor prognosis of lung adenocarcinoma (LUAD) remains unimproved. This study aimed to identify lymph node metastasis (LNM)-related and cellular imm...
Clear cell renal cell carcinoma (ccRCC) is distinguished by the absence of definitive diagnostic markers and efficacious treatment modalities, factors...